Georg Zimmermann

Position: Postdoc-Position - Leiter des Teams "Biostatistics & Big Medical Data - PMU"

E-Mail: georg.zimmermann@pmu.ac.at

Veröffentlichungen

S. Clemens, C. Simon, W. Lauth, O. Rose, G. Zimmermann, et al.: Development and Validation of a risk prediction tool for drug-related problems in pre-operative elective surgical patients (mediPORT): A case-control study. (2025) https://doi.org/https://doi.org/10.1371/journal.pone.0326088
M. Delporte, J. Verbeck, I. Brambilla, G. Zimmermann, G. Molenberghs, et al.: Dravet syndrome: Insights into seizure and speech progression from registry data. (2025) https://doi.org/https://doi.org/10.1016/j.yebeh.2025.110459
V. Wally, T. Welponer, H. P. Wiesinger, A. Diem, K. Thiel, M. Geroldinger, G. Zimmermann, et al.: Keratin-associated epidermolysis bullosa simplex: phenotypes and challenges in clinical trials – a narrative review and systematic update. (2025) https://doi.org/https://doi.org/10.1186/s13023-025-03822-0
J. Verbeeck, M. Geroldinger, J. Nyberg, K. E. Thiel, A. Bathke, G. Zimmermann, et al.: Reflection on clinical and methodological issues in rare disease clinical trials. (2025) https://doi.org/ https://doi.org/10.1186/s13023-025-03805-1
M. C. Hribljan, G. Zimmermann, S. Beniczky: Lateralizing value of ictal head turning: A systematic review and meta-analysis. (2025) https://doi.org/https://doi.org/10.1002/epd2.70046
M. Laimer, A. P. South, E. Mayer, S. Kitzmueller, L. Banner, M. A. Hosler, G. Zimmermann, et al.: Efficacy and safety of rigosertib in patients with recessive dystrophic epidermolysis bullosa-associated advanced/metastatic cutaneous squamous cell carcinoma. (2025) https://doi.org/https://doi.org/10.1093/bjd/ljaf205
A. E. Carrozzo, G. Zimmermann, A. Bathke, D. Neunhaeuserer, et al.: Two-Arm Crossover Randomized Controlled Trial Versus Meta-Analysis of N-of-1 Studies: Comparison of Statistical Efficiency in Determining an Intervention Effect. (2025) https://doi.org/https://doi.org/10.1002/bimj.70045
A. M. Wiesinger, B. Bigger, R. Giugliani, C. Lampe, G. Zimmermann, et al.: Development of a novel tool for individual treatment trials in mucopolysaccharidosis. (2024) https://doi.org/https://doi.org/10.1002/jimd.12816
M. Oeller, T. Schally, G. Zimmermann, W. Lauth, K. Schallmoser, E. Rohde, S. Laner-Plamberger: Heparin Differentially Regulates the Expression of Specific miRNAs in Mesenchymal Stromal Cells. (2024) https://doi.org/https://doi.org/10.3390/ijms252312589
J. Nyberg, G. Zimmermann, M. Geroldinger, K. E. Thiel, et al.: Optimizing designs in clinical trials with an application in treatment of Epidermolysis bullosa simplex, a rare genetic skin disease. (2024) https://doi.org/https://doi.org/10.1016/j.csda.2024.108015
A. Astner-Rohracher, G. Zimmermann, B. Frauscher, et al.: Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study. (2024) https://doi.org/https://doi.org/10.1136/bmjno-2024-000765
A. E. Carrozzo, A. Bathke, G. Zimmermann, et al.: Applying Exercise Capacity and Physical Activity as Single vs Composite Endpoints for Trials of Cardiac Rehabilitation Interventions: Rationale, Use-case, and a Blueprint Method for Sample Size Calculation. (2024) https://doi.org/ https://doi.org/10.1016/j.apmr.2024.04.004
G. Kalss, G. Zimmermann, et al.: The Fingerprint of Scalp-EEG in Drug-Resistant Frontal Lobe Epilepsies. (2024) https://doi.org/ https://doi.org/10.1097/WNP.0000000000001106
T. Pixner, W. Lauth, G. Zimmermann, et al.: Rise in fasting and dynamic glucagon levels in children and adolescents with obesity is moderate in subjects with impaired fasting glucose but accentuated in subjects with impaired glucose tolerance or type 2 diabetes. (2024) https://doi.org/ https://doi.org/10.3389/fendo.2024.1368570
A. Domnica Hoeggerl, W. Lauth, G. Zimmermann, et al.: Dissecting the dynamics of SARS-CoV-2 reinfections in blood donors with pauci- or asymptomatic COVID-19 disease course at initial infection. (2024) https://doi.org/https://doi.org/10.1080/23744235.2024.2367112
V. N. Frey, P. Langthaler, G. Zimmermann, et al.: Influence of sports on cortical excitability in patients with spinal cord injury: a TMS study. (2024) https://doi.org/https://doi.org/10.3389/fmedt.2024.1297552
P. Sattler, G. Zimmermann: Choice of the hypothesis matrix for using the Wald-type-statistic. (2024) https://doi.org/https://doi.org/10.1016/j.spl.2024.110038
K. Zeman-Kuhnert, G. Zimmermann, W. Lauth, et al.: Long-Term Outcomes of Dental Rehabilitation and Quality of Life after Microvascular Alveolar Ridge Reconstruction in Patients with Head and Neck Cancer. (2024) https://doi.org/https://doi.org/10.3390/jcm13113110
S. Schoenen, G. Zimmermann, et al.: Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populations. (2024) https://doi.org/ https://doi.org/10.1186/s13023-024-03103-2
P. Bosque Varela, G. Zimmermann, E. Trinka, et al.: Magnetic resonance imaging fingerprints of status epilepticus: A case-control study. (2024) https://doi.org/https://doi.org/10.1111/epi.17949
J. Verbeeck, M. Geroldinger, K. Thiel, […], G. Zimmermann: How to analyze continuous and discrete repeated measures in small sample cross-over trials?. (2023) https://doi.org/https://doi.org/10.1111/biom.13920
F. Berns, G. Zimmermann, C. Borgelt, et al.: Trustworthy Medical Operational AI: Marrying AI and Regulatory Requirements. (2023) https://doi.org/ https://doi.org/10.1109/BigData59044.2023.10386683
M. Geroldinger, J. Verbeeck, A.C. Hooker, K.E. Thiel, G. Molenberghs, J. Nyberg, J. Bauer, M. Laimer, V. Wally, A. Bathke, G. Zimmermann : Statistical recommendations for count, binary, and ordinal data in rare disease cross-over trials. (2023) https://doi.org/ https://doi.org/10.1186/s13023-023-02990-1
A.D. Hoeggerl, V. Nunhofer, W. Lauth, N. Badstuber, N. Held, G. Zimmermann, et al.: Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course. (2023) https://doi.org/https://doi.org/10.1186/s12879-023-08820-w
L. J. Rainer, E. Trinka, P. Langthaler, G. Zimmermann, L. Kronbichler, et al.: Recognition and Perception of emotions in juvenile myoclonic epilepsy. (2023) https://doi.org/ https://doi.org/10.1111/epi.17783
T. Moser, G. Zimmermann, et al.: Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study. (2023) https://doi.org/https://doi.org/10.1007/s00415-023-11924-7
O. Kartal, N. Lindlbauer, S. Laner-Plamberger, E. Rohde, F. Föttinger, L. Ombres, G. Zimmermann, C. Mrazek, W. Lauth, C. Grabmer : Collection efficiency of mononuclear cells in offline extracorporeal photopheresis: can processing time be shortened?. (2023) https://doi.org/ https://doi.org/10.2450/BloodTransfus.442
A.M. Wiesinger, B. Bigger, R. Giugliani, C. Lampe, M. Scarpa, T. Moser, C. Kampmann, G. Zimmermann, F.B. Lagler: An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. (2023) https://doi.org/https://doi.org/10.3390/pharmaceutics15051565
E. Trinka, L.J. Rainer, C.A. Granbichler, G. Zimmermann, M. Leitinger: Mortality, and life expectancy in Epilepsy and Status epilepticus — current trends and future aspects. (2023) https://doi.org/ https://doi.org/10.3389/fepid.2023.1081757
M. Geroldinger, J. Verbeeck, K.E. Thiel, G. Molenberghs, A. Bathke, M. Laimer, G. Zimmermann: A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases. (2023) https://doi.org/https://doi.org/10.1002/bimj.202200236
M. Genitrini, J. Fritz, G. Zimmermann, H. Schwameder: Downhill Sections Are Crucial for Performance in Trail Running Ultramarathons-A Pacing Strategy Analysis. (2022) https://doi.org/ https://doi.org/10.3390/jfmk7040103
M. Pallauf, F. Steinkohl, G. Zimmermann, et al.: External validation of two mpMRI-risk calculators predicting risk of prostate cancer before biopsy. (2022) https://doi.org/https://doi.org/10.1007/s00345-022-04119-8
S. Laner-Plamberger S, […], W. Lauth, G. Zimmermann, et al.: SARS-CoV-2 IgG Levels Allow Predicting the Optimal Time Span of Convalescent Plasma Donor Suitability. (2022) https://doi.org/https://doi.org/10.3390/diagnostics12112567
L. Machegger […], T. Prüwasser, G. Zimmermann et al.: Quantitative Analysis of Diffusion-Restricted Lesions in a Differential Diagnosis of Status Epilepticus and Acute Ischemic Stroke. (2022) https://doi.org/ https://doi.org/10.3389/fneur.2022.926381
L.J. Rainer, M. Kronbichler, G. Kuchukhidze, E. Trinka, P. Langthaler, L. Kronbichler, S. Said-Yuerekli, M. Kirschner, G. Zimmermann, J. Höfler, E. Schmid, M. Braun: Emotional Word Processing in Patients With Juvenile Myoclonic Epilepsy. (2022) https://doi.org/https://doi.org/10.3389/fneur.2022.875950
V. Nunhofer, L. Weidner, A.D. Hoeggerl, G. Zimmermann, et al.: Persistence of Naturally Acquired and Functional SARS-CoV-2 Antibodies in Blood Donors One Year after Infection. (2022) https://doi.org/ https://doi.org/10.3390/v14030637
K. Aleksovska, T. Kobulashvili, J. Costa, G. Zimmermann, et al.: European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases. (2022) https://doi.org/https://doi.org/10.1111/ene.15267
S. Roesch, A. O’Sullivan, G. Zimmermann, A. Mair, C. Lipuš, J.A. Mayr, S.B. Wortmann and G. Rasp: Mitochondrial Disease and Hearing Loss in Children: A Systematic Review. (2022) https://doi.org/ https://doi.org/10.1002/lary.30067
A. Astner-Rohracher, G. Zimmermann, T. Avigdor, et al.: Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by Stereoelectroencephalography. (2021) https://doi.org/ https://doi.org/10.1001/jamaneurol.2021.4405
A. Egger-Rainer, S.M. Hettegger, R. Feldner, S. Arnold, C. Bosselmann, H. Hamer, A. Hengsberger, J. Lang, S. Lorenzl, H. Lerche, S. Noachtar, E. Pataraia, A. Schulze-Bonhage, A.M. Staack, E. Trinka, I. Unterberger, G. Zimmermann: Do all patients in the epilepsy monitoring unit experience the same level of comfort? A quantitative exploratory secondary analysis. (2021) https://doi.org/https://doi.org/10.1111/jan.15105
G. Zimmermann, E. Brunner, W. Brannath, M. Happ, A. Bathke: Pseudo Ranks: The Better Way of Ranking?. (2021) https://doi.org/https://doi.org/10.1080/00031305.2021.1972836
F. Konietschke, C. Cao, A. Gunawardana, G. Zimmermann: Analysis of covariance under variance heteroscedasticity in general factorial designs. (2021) https://doi.org/https://doi.org/10.1002/sim.9092
L. Weidner, V. Nunhofer, C. Jungbauer, A.D. Hoeggerl, L. Grüner, C. Grabmer, G. Zimmermann, E. Rohde, S. Laner-Plamberger: Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors. (2021) https://doi.org/ https://doi.org/10.1007/s15010-021-01639-0
J. Pilz, L. Hehenwarter, G. Zimmermann, G. Rendl, G. Schweighofer-Zwink, M. Beheshti, C. Pirich: Feasibility of equivalent performance of 3D TOF [18F]-FDG PET/CT with reduced acquisition time using clinical and semiquantitative parameters. (2021) https://doi.org/ https://doi.org/10.1186/s13550-021-00784-9
T. Kiesslich, M. Beyreis, G. Zimmermann, A. Traweger: Citation inequality and the Journal Impact Factor: median, mean, (does it) matter? . (2020) https://doi.org/ https://doi.org/10.1007/s11192-020-03812-y
G. Zimmermann: To rank or to permute when comparing an ordinal outcome between two groups while adjusting for a covariate?. (2020) https://doi.org/ https://doi.org/10.1007/978-3-030-57306-5_48
M. Leitinger, K.N. Poppert, M. Mauritz, F. Rossini, G. Zimmermann, A. Rohracher, G. Kalss, G. Kuchukhidze, J. Höfler, P. Bosque Varela, R. Kreidenhuber, K. Volna, C. Neuray, T. Kobulashvili, C.A. Granbichler, U. Siebert, E. Trinka: Status epilepticus admissions during the COVID-19 pandemic in Salzburg. A population-based study. (2020) https://doi.org/https://doi.org/10.1111/epi.16737
G. Zimmermann, E. Trinka: Accounting for individual variability in baseline seizure frequencies when planning randomized clinical trials remains challenging. (2020) https://doi.org/https://doi.org/10.1111/epi.16676
A. Egger-Rainer, E. Trinka, G. Zimmermann, S. Arnold, C. Boßelmann, H. Hamer, A. Hengsberger, J. Lang, H. Lerche, S. Noachtar, E. Pataraia, A. Schulze-Bonhage, A.M. Staack, I. Unterberger, S. Lorenzl: Assessing comfort in the epilepsy monitoring unit: Psychometric testing of an instrument. (2020) https://doi.org/ https://doi.org/10.1016/j.yebeh.2020.107460